Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.

J. S. Chu, W. J. Lee, K. M. Chen, H. C. Hsu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

To elucidate the frequency and biological significance of the expression of estrogen receptor (ER), progesterone receptor (PR), and neu oncogene in breast carcinoma, ER, PR and neu proteins were examined by immunohistochemical assay in 74 Taiwanese patients with breast carcinoma. In total, 56.8% and 48.7% of breast carcinoma were positive for ER and PR, respectively. In 91.9% of cases, the patients were either positive (48.7%) or negative (43.2%) for both ER and PR. Well differentiated carcinoma had higher frequencies of ER- (p <0.02) and PR-positivities (p <0.01). The ER and PR status did not correlate with tumor size, stromal lymphoid infiltration or axillary node status. The neu oncoprotein was expressed in 25.7% of breast carcinomas, but did not correlate with ER and PR status, tumor size, tumor grade, lymphoid infiltration, or axillary node status.

Original languageEnglish
Pages (from-to)277-282
Number of pages6
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume93
Issue number4
Publication statusPublished - Apr 1994
Externally publishedYes

Fingerprint

Progesterone Receptors
Estrogen Receptors
Breast Neoplasms
Neoplasms
Oncogene Proteins
Oncogenes
Carcinoma
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma. / Chu, J. S.; Lee, W. J.; Chen, K. M.; Hsu, H. C.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 93, No. 4, 04.1994, p. 277-282.

Research output: Contribution to journalArticle

@article{eac439da373e43f08837f8e9788dfaa1,
title = "Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.",
abstract = "To elucidate the frequency and biological significance of the expression of estrogen receptor (ER), progesterone receptor (PR), and neu oncogene in breast carcinoma, ER, PR and neu proteins were examined by immunohistochemical assay in 74 Taiwanese patients with breast carcinoma. In total, 56.8{\%} and 48.7{\%} of breast carcinoma were positive for ER and PR, respectively. In 91.9{\%} of cases, the patients were either positive (48.7{\%}) or negative (43.2{\%}) for both ER and PR. Well differentiated carcinoma had higher frequencies of ER- (p <0.02) and PR-positivities (p <0.01). The ER and PR status did not correlate with tumor size, stromal lymphoid infiltration or axillary node status. The neu oncoprotein was expressed in 25.7{\%} of breast carcinomas, but did not correlate with ER and PR status, tumor size, tumor grade, lymphoid infiltration, or axillary node status.",
author = "Chu, {J. S.} and Lee, {W. J.} and Chen, {K. M.} and Hsu, {H. C.}",
year = "1994",
month = "4",
language = "English",
volume = "93",
pages = "277--282",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.

AU - Chu, J. S.

AU - Lee, W. J.

AU - Chen, K. M.

AU - Hsu, H. C.

PY - 1994/4

Y1 - 1994/4

N2 - To elucidate the frequency and biological significance of the expression of estrogen receptor (ER), progesterone receptor (PR), and neu oncogene in breast carcinoma, ER, PR and neu proteins were examined by immunohistochemical assay in 74 Taiwanese patients with breast carcinoma. In total, 56.8% and 48.7% of breast carcinoma were positive for ER and PR, respectively. In 91.9% of cases, the patients were either positive (48.7%) or negative (43.2%) for both ER and PR. Well differentiated carcinoma had higher frequencies of ER- (p <0.02) and PR-positivities (p <0.01). The ER and PR status did not correlate with tumor size, stromal lymphoid infiltration or axillary node status. The neu oncoprotein was expressed in 25.7% of breast carcinomas, but did not correlate with ER and PR status, tumor size, tumor grade, lymphoid infiltration, or axillary node status.

AB - To elucidate the frequency and biological significance of the expression of estrogen receptor (ER), progesterone receptor (PR), and neu oncogene in breast carcinoma, ER, PR and neu proteins were examined by immunohistochemical assay in 74 Taiwanese patients with breast carcinoma. In total, 56.8% and 48.7% of breast carcinoma were positive for ER and PR, respectively. In 91.9% of cases, the patients were either positive (48.7%) or negative (43.2%) for both ER and PR. Well differentiated carcinoma had higher frequencies of ER- (p <0.02) and PR-positivities (p <0.01). The ER and PR status did not correlate with tumor size, stromal lymphoid infiltration or axillary node status. The neu oncoprotein was expressed in 25.7% of breast carcinomas, but did not correlate with ER and PR status, tumor size, tumor grade, lymphoid infiltration, or axillary node status.

UR - http://www.scopus.com/inward/record.url?scp=0028415659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028415659&partnerID=8YFLogxK

M3 - Article

C2 - 7914767

AN - SCOPUS:0028415659

VL - 93

SP - 277

EP - 282

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 4

ER -